Labcorp Reaffirms 2026 Guidance, Aims for 5% to 8% Rev Growth Through 2029

Labcorp disclosed a long-term outlook targeting 5% to 8% annualized revenue growth and margin expansion through 2029. The announcement is significant for the diagnostics sector and underscores the company's strategic alignment with scientific innovation.